FDG-PET of the Thyroid
DOWNLOAD FACT SHEET IN PDF

References:

1) Cooper DS, Doherty GM, Haugen BR. Revised American Thyroid Association Management
Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009;19
(11):1167-1214 [PDF]

2) American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and
European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and
Management of Thyroid Nodules. Gharib H, Papini E, Paschke R. Endocr Pract 2010;16(Suppl 1):
1-43 [PDF]

3) Cohen MS, Arslan N, Dehdashti F. Risk of malignancy in thyroid incidentalomas identified by
fluorodeoxyglucose-positron emission tomography. Surgery 2001;130:941-946 [PDF]

4) Chen YK, Ding HJ, Chen KT. Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma
Identified by 18F-Fluorodeoxyglucose Positron Emission Tomography for Cancer Screening in
Healthy Subjects. Anticancer Research 2005;25:1421-1426 [PDF]

5) Kim TY, Kim WB, Ryu JS. 18F-Fluorodeoxyglucose Uptake in Thyroid from Positron Emission
Tomogram (PET) for Evaluation in Cancer Patients: High Prevalence of Malignancy in Thyroid
PET Incidentaloma. Laryngoscope 2005;115:1074-1078 [PDF]

6) Are C, Hsu JF, Schoder H. FDG-PET Detected Thyroid Incidentalomas: Need for Further
Investigation? Annals of Surgical Oncology 2006;14(1):239-247 [PDF]

7) Choi JY, Lee KS, Kim HJ. Focal Thyroid Lesions Incidentally Identified by Integrated 18F-FDG
PET/CT: Clinical Significance and Improved Characterization. J Nucl Med 2006;347:609-615
[PDF]

8) Kim BH, Kim IJ, Kim SJ. Risk stratification and prediction of cancer of focal thyroid
fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 2010;24:721-728 [PDF]

9) Wong C, Lin M, Chicco A. The clinical significance and management of incidental focal FDG
uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT)
in patients with non-thyroidal malignancy. Acta Radiologica 2011;52:899-904 [PDF]

10) Pagano L, Sama MT, Morani F. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose
positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
Clinical Endocrinology 2011;75:528-534 [PDF]

11) Yasuda S, Shohtsu A, Ide M. Chronic Thyroiditis: Diffuse Uptake of FDG at PET. Radiology
1998;207:775-778 [PDF]

12) Yi JG, Marom EM, Munden RF. Focal Uptake of Fluorodeoxyglucose by the Thyroid in
Patients Undergoing Initial Disease Staging with Combined PET/CT for Non-small Cell Lung
Cancer. Radiology 2005;236:271-275 [PDF]

13) Kwak JY, Kim EK, Yun M. Thyroid Incidentalomas Identified by 18F-FDG PET: Sonographic
Correlation. AJR 2008;191:598-603 [PDF]

14) Karantanis D, Bogsrud TV, Wiseman GA. Clinical Significance of Diffusely Increased 18F-
FDG Uptake in the Thyroid Gland. J Nucl Med 2007;48:896-901 [PDF]

15) Ramos CD, Chisin R, Yeung HWD. Incidental Focal Thyroid Uptake on FDG Positron
Emission Tomographic Scans May Represent a Second Primary Tumor. Clinical Nuclear
Medicine 2001;26(3):193-197 [PDF]

16) Kang KW, Kim SK, Kang HS. Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma
Identified by 18F-Fluorodeoxyglucose Positron Emission Tomography for Metastasis Evaluation
and Cancer Screening in Healthy Subjects. J Clin Endocrinol Metab 2003;88:4100-4104 [PDF]

17) Van Den Bruel A, Maes A, Potter TD. Clinical Relevance of Thyroid Fluorodeoxyglucose-
While Body Positron Emission Tomography Incidentaloma. J Clin Endocrinol Metab 2002;87:
1517-1520 [PDF]

18) Bae JS, Chae BJ, Park WC. Incidental thyroid lesions detected by FDG-PET/CT: prevalence
and risk of thyroid cancer. World Journal of Surgical Oncology 2009;7:63 [PDF]

19) Eloy JA, Brett EM, Fatterpekar GM. The Significance and Management of Incidental [18F]
Fluorodeoxyglucose-Positron-Emission Tomography Uptake in the Thyroid Gland in Patients
with Cancer. Am J Neuroradiol 2009;30:1431-1434 [PDF]

20) Blodgett TM, Fukui MB, Snyderman CH. Combined PET-CT in the Head and Neck: Part 1.
Physiologic, Altered Physiologic, and Artifactual FDG Uptake. Radiographics 2005;25:897-912
[PDF]

21) Rosenbaum SJ, Lind T, Antoch G. False-Positive FDG PET Uptake – the Role of PET/CT. Eur
Radiol 2006;16:1054-1065 [PDF]

22) Liu Y, Ghesani NV, Zuckier LS. Physiology and Pathophysiology of Incidental Findings
Detected on FDG-PET Scintigraphy. Semin Nucl Med 2010;40:294-315 [PDF]

23) Nilsson IL, Arnberg F, Zedenius J. Thyroid Incidentaloma Detected by Fluorodeoxyglucose
Positron Emission Tomography/Computed Tomography: Practical Management Algorithm.
World J Surg 2011;35:2691-2697 [PDF]

24) King DL, Stack BC, Spring PM. Incidence of thyroid carcinoma in fluorodeoxyglucose
positron emission tomography-positive thyroid incidentalomas. Otolaryngology--Head and Neck
Surgery 2007;137:400-404 [PDF]

25) Chu QD, Connor MS, Lilien DL. Positron Emission Tomography (PET) Positive Thyroid
Incidentaloma: The Risk of Malignancy Observed in a Tertiary Referral Center. Am Surg 2006;72
(3):272-275 [PDF]

26) Liu Y. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission
tomography. Ann Nucl Med 2009;23:17-23 [PDF]

27) Chen YK, Chen YL, Cheng RH. The significance of FDG uptake in bilateral thyroid glands.
Nucl Med Commun 2007;28:117-122 [PDF]

28) Chen YK, Chen YL, Liao AC. Elevated F18-FDG-PET uptake in skeletal muscle and thymus: a
clue for the diagnosis for Graves' disease. Nucl Med Commun 2004;25:115-121 [PDF]

29) Wolf G, Aigner RM, Schaffler G. Pathologic results in F18-FDG-PET of the thyroid gland. Nucl
Med Commun 2003;24:1225-1230 [PDF]

30) Shie P, Cardarelli R, Sprawls K. Systematic review: prevalence of malignant incidental
thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography.
Nucl Med Commun 2009;3:742-748 [PDF]

31) Kurata S, Ishibashi M, Hirromatsu Y. Diffuse and diffuse-plus-focal uptake in the thyroid
gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Ann Nucl med 2007;21:325-330 [PDF]

32) Chen YK, Wang YF, Chiu JS. Diagnostic trinity: Graves' disease on F18-FDG PET. Clin Nucl
Med 2007;32:816-817 [PDF]

33) Chen YK, Chen YL. Elevated F18-FDG uptake in the thymus in Graves’ disease. Clin Nucl Med
2003;28:142-143 [PDF]

34) Salvatori M, Melis L, Castaldi P. Clinical significance of focal and diffuse thyroid diseases
identified by 18F-fluorodeoxyglucose positron emission tomography. Biomedicine and
Pharmacotherapy 2007;61(8):488-493 [PDF]

35) Bogsrud TV, Karantanis D, Nathan MA. The value of quantifying 18F-FDG uptake in thyroid
nodules found incidentally on whole-body PET-CT. Nucl Med Commun 2007;28:373-381 [PDF]

36) Liu Y. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial
tumors. Nucl Med Commun 2011;32:554-562 [PDF]

37) Chen W, Li G, Parsons M. Clinical Significance of Incidental Focal Versus Diffuse Thyroid
Uptake on FDG-PET Imaging. PET Clin 2008;2:321-329 [PDF]